Pharmaceutical Waste Management - The Pyxis ® Insider newsletter

More documents

Recommendations

Info

Formulary Assessment of <strong>Waste</strong>• Collaborative formulary assessmentœ NIOSH Appendix A & IARCœ State and Federal regulationsœ <strong>Waste</strong> hauler processDRUG - GENERIC(BRAND)CLASS OFMEDICATIONROUTES/FORMSCOMPANYPREGNANCYCATEGORY MSDS BSCHAZCLASS(1-4)WASTESTREAMAldesleukin(Proleukin) ONC INJ Chrion C YES Yes Class 1 YELLOW NAlemtuzumab(Campth) ONC INJ Berlex C YES Yes Class 1 YELLOW NAlitretinoin(Panretin)Altretamine(Hexalen)RetinoidONCTOPICAL,GEL Ligand D YESORAL,CAPSULE MGI D YESYes, ifaltered Class 1 YELLOW NYes, ifaltered Class 1 YELLOW NRCRA Y/NœContinuous assessment of Risk and Stream
N=343 Rx Directors
Page 1 and 2: Pharmaceutical Waste ManagementFiro
Page 3 and 4: • March & September 2008œ Health
Page 5 and 6: Environmental Effects• Steroid pl
Page 7 and 8: US Regulatory Bodies for RX WastesP
Page 9 and 10: Pending Legislation• Drug Free Wa
Page 11 and 12: What Drug Waste is Regulated?• So
Page 13 and 14: P-listedDrug, vials and packagingEP
Page 15 and 16: EPA Defined Hazardous DrugsD-Listed
Page 17 and 18: Risk Management & Liability• Civi
Page 19 and 20: DOT Manifest for TransportStandard
Page 21 and 22: EPA’s Current StatusNo Health-sys
Page 23 and 24: Think of All Areas WhereDrugs Are H
Page 25 and 26: Biohazard Sharps Containers• “U
Page 27 and 28: Aerosolized Drug Products• Highly
Page 29: Medicinal Leeches and MaggotsBiohaz
Page 33 and 34: Model IIElectronic Devices for RX W
Page 35 and 36: Model IVManaging All RX Waste as Ha
Page 37 and 38: Proper Hazardous Drug Waste Disposa
Page 39 and 40: N=343 Rx Directors
Page 41: Pharmaceutical Waste ManagementFiro

Pharmaceutical Waste Management - The Pyxis ® Insider newsletter

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?